Key Financial Data Of Group

Solasia Pharma K.K. - Filing #7337315

Concept 2024-01-01 to
2024-03-31
As at
2024-03-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-03-31
As at
2023-03-31
Key financial data of group
Business results of group
Revenue
11,000,000 JPY
617,000,000 JPY
220,000,000 JPY
Profit (loss) before tax
-318,000,000 JPY
-1,135,000,000 JPY
-247,000,000 JPY
Profit (loss), attributable to owners of parent
-310,000,000 JPY
-1,112,000,000 JPY
-241,000,000 JPY
Comprehensive income, attributable to owners of parent
-300,000,000 JPY
-1,103,000,000 JPY
-237,000,000 JPY
Equity attributable to owners of parent
1,823,000,000 JPY
1,875,000,000 JPY
2,424,000,000 JPY
Total assets
2,708,000,000 JPY
2,229,000,000 JPY
2,989,000,000 JPY
Basic earnings (loss) per share
-1.78
-6.62
-1.44
Diluted earnings (loss) per share
-1.78
-6.62
-1.44
Ratio of owners' equity to gross assets
0.673 xbrli:pure
0.841 xbrli:pure
0.811 xbrli:pure
Cash flows from (used in) operating activities
-164,000,000 JPY
-359,000,000 JPY
223,000,000 JPY
Cash flows from (used in) investing activities
JPY
0 JPY
0 JPY
Cash flows from (used in) financing activities
743,000,000 JPY
275,000,000 JPY
-12,000,000 JPY
Cash and cash equivalents
1,319,000,000 JPY
728,000,000 JPY
1,016,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.